Cinctive Capital Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-64,828
Closed -$1.75M 504
2024
Q3
$1.75M Sell
64,828
-46,629
-42% -$1.19M 0.1% 243
2024
Q2
$2.78M Buy
+111,457
New +$3.2M 0.13% 212
2023
Q3
Sell
-272,899
Closed -$10.9M 508
2023
Q2
$10.9M Buy
+272,899
New +$10.9M 0.36% 80
2022
Q4
Sell
-70,129
Closed -$1.99M 549
2022
Q3
$1.99M Buy
70,129
+40,129
+134% +$1.37M 0.08% 283
2022
Q2
$1.07M Buy
+30,000
New +$1.21M 0.05% 391
2022
Q1
Sell
-65,781
Closed -$3.67M 679
2021
Q4
$3.67M Buy
+65,781
New +$3.62M 0.16% 209
2020
Q4
Sell
-41,395
Closed -$1.81M 417
2020
Q3
$1.81M Buy
+41,395
New +$1.83M 0.16% 222

Other funds holding XRAY

Cinctive Capital Management's XRAY Position: Q4 2024 in Review

Cinctive Capital Management sold out of Dentsply Sirona (XRAY) in Q4 2024, closing a stake of 64,828 shares — an estimated $1.75M sold.

Cinctive Capital Management first reported a position in XRAY in Q3 2020 and held it in 7 quarters. The position peaked at $10.9M in Q2 2023. 359 funds tracked by Wall St. Rank hold XRAY as of Q4 2024.

  • Cinctive Capital Management reported no remaining Dentsply Sirona position as of Q4 2024 after selling out during the quarter.
  • Cinctive Capital Management sold 64,828 Dentsply Sirona shares in Q4 2024, an estimated $1.75M.
  • Cinctive Capital Management first reported a position in Dentsply Sirona in Q3 2020 and held it in 7 quarters.
  • Cinctive Capital Management's Dentsply Sirona position peaked at $10.9M in Q2 2023.
  • 359 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2024.

Based on Cinctive Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.